EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Inter-Species Pharmacokinetic Modeling and Scaling for Drug Repurposing of Pyronaridine and Artesunate

Dong Wook Kang iD, Ju Hee Kim, Kyung Min Kim, Seok-Jin Cho iD, Go-Wun Choi iD, Hea-Young Cho iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25136998 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Dong Wook Kang und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, CHA University, 335 Pangyo-ro, Bundang-gu, Seongnam-si 13488, Gyeonggi-do, Republic of Korea. Hauptthemen laut MEDLINE: Artesunate, Drug Repositioning, Naphthyridines, Artemisinins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Even though several new targets (mostly viral infection) for drug repurposing of pyronaridine and artesunate have recently emerged in vitro and in vivo, inter-species pharmacokinetic (PK) data that can extend nonclinical efficacy to humans has not been reported over 30 years of usage. Since extrapolation of animal PK data to those of humans is essential to predict clinical outcomes for drug repurposing, this study aimed to investigate inter-species PK differences in three animal species (hamster, rat, and dog) and to support clinical translation of a fixed-dose combination of pyronaridine and artesunate. PK parameters (e.g., steady-state volume of distribution (Vss), clearance (CL), area under the concentration-time curve (AUC), mean residence time (MRT), etc.) of pyronaridine, artesunate, and dihydroartemisinin (an active metabolite of artesunate) were determined by non-compartmental analysis. In addition, one- or two-compartment PK modeling was performed to support inter-species scaling. The PK models appropriately described the blood concentrations of pyronaridine, artesunate, and dihydroartemisinin in all animal species, and the estimated PK parameters in three species were integrated for inter-species allometric scaling to predict human PKs. The simple allometric equation (Y = a × Wb) well explained the relationship between PK parameters and the actual body weight of animal species. The results from the study could be used as a basis for drug repurposing and support determining the effective dosage regimen for new indications based on in vitro/in vivo efficacy data and predicted human PKs in initial clinical trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ArtesunateDrug RepositioningNaphthyridinesArtemisininsAnimalsRatsDogsSpecies SpecificityHumansModels, BiologicalMaleAntimalarials

Stichwörter der Autor:innen

allometric scalingartesunatedrug repurposinginter-species scalingpharmacokineticspyronaridine

Substanzen

ArtesunatepyronaridineNaphthyridinesArtemisininsAntimalarials

Autor:innen und Institutionen

  • College of Pharmacy, CHA University, 335 Pangyo-ro, Bundang-gu, Seongnam-si 13488, Gyeonggi-do, Republic of Korea.

ORCID-Profile: Dong Wook Kang, Seok-Jin Cho, Go-Wun Choi, Hea-Young Cho

Zitieren

APA

Kang, D. W., Kim, J. H., Kim, K. M., Cho, S. J., Choi, G. W., & Cho, H. Y. (2024). Inter-Species Pharmacokinetic Modeling and Scaling for Drug Repurposing of Pyronaridine and Artesunate. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25136998

Vancouver

Kang DW, Kim JH, Kim KM, Cho SJ, Choi GW, Cho HY. Inter-Species Pharmacokinetic Modeling and Scaling for Drug Repurposing of Pyronaridine and Artesunate. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25136998

BibTeX
@article{Kang2024,
  author = {Kang, Dong Wook and Kim, Ju Hee and Kim, Kyung Min and Cho, Seok-Jin and Choi, Go-Wun and Cho, Hea-Young},
  title = {Inter-Species Pharmacokinetic Modeling and Scaling for Drug Repurposing of Pyronaridine and Artesunate},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25136998}
}
Kostenlos starten →